ETR:FME - Fresenius Medical Care AG & Co. KGaA Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €67.64 +0.14 (+0.21 %) (As of 05/24/2019 04:00 PM ET)Previous Close€67.64Today's Range€67.24 - €68.1052-Week Range€55.44 - €91.74Volume631,449 shsAverage Volume704,197 shsMarket Capitalization$20.51 billionP/E Ratio10.53Dividend Yield1.56%BetaN/A ProfileAnalyst RatingsChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Receive FME News and Ratings via Email Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ETR Industry Medical Care Sub-IndustryN/A SectorMedical Current SymbolETR:FME Previous Symbol CUSIPN/A CIKN/A Webhttp://www.freseniusmedicalcare.com/ Phone+49-6172-6090Debt Debt-to-Equity Ratio100.05 Current Ratio1.02 Quick Ratio0.67Price-To-Earnings Trailing P/E Ratio10.53 Forward P/E Ratio15.30 P/E GrowthN/A Sales & Book Value Annual Sales$16.70 billion Price / Sales1.23 Cash Flow€3.07 per share Price / Cash Flow22.04 Book Value€39.47 per share Price / Book1.71Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees112,658 Outstanding Shares303,233,984Market Cap$20.51 billion Next Earnings Date7/30/2019 (Estimated) OptionableNot Optionable Fresenius Medical Care AG & Co. KGaA (ETR:FME) Frequently Asked Questions What is Fresenius Medical Care AG & Co. KGaA's stock symbol? Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME." When is Fresenius Medical Care AG & Co. KGaA's next earnings date? Fresenius Medical Care AG & Co. KGaA is scheduled to release their next quarterly earnings announcement on Tuesday, July 30th 2019. View Earnings Estimates for Fresenius Medical Care AG & Co. KGaA. What price target have analysts set for FME? 19 Wall Street analysts have issued 12-month price targets for Fresenius Medical Care AG & Co. KGaA's shares. Their predictions range from €68.00 to €102.00. On average, they expect Fresenius Medical Care AG & Co. KGaA's stock price to reach €82.81 in the next twelve months. This suggests a possible upside of 22.4% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co. KGaA. What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co. KGaA? 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 8 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius Medical Care AG & Co. KGaA. Has Fresenius Medical Care AG & Co. KGaA been receiving favorable news coverage? News articles about FME stock have been trending positive on Saturday, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Fresenius Medical Care AG & Co. KGaA earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days. Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors? Some companies that are related to Fresenius Medical Care AG & Co. KGaA include Sonic Healthcare (SHL), NMC Health (NMC), Mediclinic International (MDC), Healius (HLS), Rhoen Klinikum (RHK), Greencross (GXL), Spire Healthcare Group (SPI), CareTech (CTH), Virtus Health (VRT), Georgia Healthcare Group (GHG), Pacific Smiles Group (PSQ), Assure (IOM), CENTRIC HEALTH (CHH), Konekt (KKT) and Brain Resource (BRC). What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Petra Diamonds (PDL), Nokia Oyj (NOKIA), Fresenius Medical Care AG & Co. (FMS), RWE (RWE), Rio Tinto (RIO), Carillion (CLLN), Oxford BioMedica (OXB), Nokia Oyj (NOK), AT&T (T) and Paypal (PYPL). Who are Fresenius Medical Care AG & Co. KGaA's key executives? Fresenius Medical Care AG & Co. KGaA's management team includes the folowing people: Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57) What is Fresenius Medical Care AG & Co. KGaA's stock price today? One share of FME stock can currently be purchased for approximately €67.64. How big of a company is Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA has a market capitalization of $20.51 billion and generates $16.70 billion in revenue each year. Fresenius Medical Care AG & Co. KGaA employs 112,658 workers across the globe. What is Fresenius Medical Care AG & Co. KGaA's official website? The official website for Fresenius Medical Care AG & Co. KGaA is http://www.freseniusmedicalcare.com/. How can I contact Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090. MarketBeat Community Rating for Fresenius Medical Care AG & Co. KGaA (ETR FME)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 876 (Vote Outperform)Underperform Votes: 569 (Vote Underperform)Total Votes: 1,445MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. KGaA and other stocks. Vote "Outperform" if you believe FME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FME will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/25/2019 by MarketBeat.com StaffFeatured Article: Outstanding Shares Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.